GS
ELV icon

GAM Systematic’s Elevance Health ELV Stock Holding History

GAM Systematic’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$3.06M Buy
16,134
+506
+3% +$96.3K 0.44% 38
2017
Q2 		$2.94M Buy
15,628
+4,659
+42% +$837K 0.42% 41
2017
Q1 		$1.81M Buy
10,969
+6,866
+167% +$1.09M 0.36% 64
2016
Q4 		$590K Sell
4,103
-2,094
-34% -$280K 0.14% 291
2016
Q3 		$777K Buy
6,197
+4,114
+198% +$531K 0.16% 263
2016
Q2 		$274K Buy
+2,083
New +$285K 0.07% 446
2016
Q1 		– Sell
-980
Closed -$137K – 643
2015
Q4 		$137K Sell
980
-2,469
-72% -$340K 0.04% 507
2015
Q3 		$483K Sell
3,449
-2,819
-45% -$424K 0.11% 349
2015
Q2 		$1.03M Sell
6,268
-4,550
-42% -$727K 0.13% 252
2015
Q1 		$1.67M Buy
10,818
+2,122
+24% +$302K 0.23% 185
2014
Q4 		$1.09M Buy
+8,696
New +$1.07M 0.22% 196

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

GAM Systematic's ELV Position: Q3 2017 in Review

GAM Systematic increased its Elevance Health (ELV) stake by 3.2% in Q3 2017, buying an estimated $96.3K and bringing the position to 16,134 shares worth $3.06M. The position accounts for 0.44% of the portfolio, ranked #38.

GAM Systematic first reported a position in ELV in Q4 2014 and has held it in 11 quarters since. 844 funds tracked by Wall St. Rank hold ELV as of Q3 2017.

  • GAM Systematic held 16,134 shares of Elevance Health worth $3.06M as of Q3 2017.
  • GAM Systematic bought 506 Elevance Health shares in Q3 2017, an estimated $96.3K.
  • Elevance Health made up 0.44% of GAM Systematic's portfolio in Q3 2017, its #38 holding.
  • GAM Systematic first reported a position in Elevance Health in Q4 2014 and has held it in 11 quarters since.
  • 844 funds tracked by Wall St. Rank held Elevance Health as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.